Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alumis Inc | 5,584,889 | 5,779,348 | +194,459 | $59.65M | $45.43M | 37.79% | -$14.22M |
| Hims & Hers Health, Inc.CL A(HIMS) | 1,759,314 | 939,860 | -819,454 | $32.41M | $22.73M | 18.91% | -$9.68M |
| CG Oncology, Inc.(CGON) | 692,550 | 692,550 | 0 | $26.13M | $19.86M | 16.53% | -$6.27M |
| Disc Medicine, Inc.(IRON) | 299,069 | 299,069 | 0 | $14.70M | $18.96M | 15.78% | +$4.26M |
| Cullinan Therapeutics, Inc.(CGEM) | 657,905 | 657,905 | 0 | $11.01M | $8.01M | 6.67% | -$3.00M |
| Lyell Immunopharma, Inc.(LYEL) | 0 | 8,133,047 | +8,133,047 | $0 | $5.21M | 4.33% | +$5.21M |